Biocon Limited

NSEI:BIOCON Stock Report

Market Cap: ₹579.5b

Biocon Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Shreehas Tambe

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4yrs

Recent management updates

Recent updates

Calculating The Fair Value Of Biocon Limited (NSE:BIOCON)

Dec 25
Calculating The Fair Value Of Biocon Limited (NSE:BIOCON)

Investors Don't See Light At End Of Biocon Limited's (NSE:BIOCON) Tunnel

Dec 07
Investors Don't See Light At End Of Biocon Limited's (NSE:BIOCON) Tunnel

Weak Statutory Earnings May Not Tell The Whole Story For Biocon (NSE:BIOCON)

Nov 19
Weak Statutory Earnings May Not Tell The Whole Story For Biocon (NSE:BIOCON)

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 22
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 56% Above Its Share Price

Biocon Limited Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10
Biocon Limited Just Missed Earnings - But Analysts Have Updated Their Models

Pinning Down Biocon Limited's (NSE:BIOCON) P/E Is Difficult Right Now

Aug 04
Pinning Down Biocon Limited's (NSE:BIOCON) P/E Is Difficult Right Now

Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jun 19
Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50

Jun 18
Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50

Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50

May 12
Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50
User avatar

Tactical Biosimilars Expansion And Viatris Integration Will Propel Revenue Growth And Boost Profitability

Strategic cost improvements and production efficiencies are set to enhance margins and profitability in the generics segment.

CEO

Shreehas Tambe (51 yo)

no data
Tenure
₹8,133,384
Compensation

Mr. Shreehas Pradeep Tambe, MTech, is CEO, MD & Additional Director of Biocon Limited from April 1, 2026. He has been Managing Director and Chief Executive Officer of Biocon Biologics Limited since Decembe...

Board Members

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson47.4yrs₹42.28m29.94%
₹ 173.5b
Shreehas Tambe
CEO, MD & Additional Directorno data₹8.13mno data
Ravi Mazumdar
Non-Executive Non-Independent Director25.7yrs₹6.80m0.33%
₹ 1.9b
Bobby Parikh
Independent Non-Executive Director7.8yrs₹8.33mno data
Naina Lal Kidwai
Lead Independent Director4yrs₹6.80mno data
Satish Garg
Member of Scientific Advisory Boardno datano datano data
Nicholas Haggar
Independent Director2.4yrs₹7.56mno data
Shashank Joshi
Member of Scientific Advisory Boardno datano datano data
Rekha Menon
Independent Director2.8yrs₹6.63mno data
Eric Mazumdar
Non-Executive Director4.4yrs₹5.95m0.20%
₹ 1.1b
John Petrie
Member of Scientific Advisory Boardno datano datano data
Atul Dhawan
Non-Executive and Independent Director1.9yrs₹6.63mno data
4.0yrs
Average Tenure
66yo
Average Age

Experienced Board: BIOCON's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/20 11:33
End of Day Share Price 2026/04/20 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biocon Limited is covered by 42 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Meeta ShettyAsian Markets Securities Private Limited
Harith AhamedAvendus Spark
Vijayaraghavan SwaminathanAvendus Spark